Folger Nolan Fleming Douglas Capital Management Inc. Trims Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Folger Nolan Fleming Douglas Capital Management Inc. lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% in the 4th quarter, HoldingsChannel reports. The fund owned 23,779 shares of the healthcare conglomerate’s stock after selling 247 shares during the period. UnitedHealth Group accounts for about 1.4% of Folger Nolan Fleming Douglas Capital Management Inc.’s portfolio, making the stock its 20th biggest holding. Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in UnitedHealth Group were worth $12,519,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Unique Wealth Strategies LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $928,000. Consolidated Planning Corp raised its position in UnitedHealth Group by 0.7% during the 4th quarter. Consolidated Planning Corp now owns 15,079 shares of the healthcare conglomerate’s stock worth $7,939,000 after buying an additional 107 shares during the last quarter. Alliance Wealth Advisors LLC UT raised its position in UnitedHealth Group by 1.3% during the 4th quarter. Alliance Wealth Advisors LLC UT now owns 5,495 shares of the healthcare conglomerate’s stock worth $2,893,000 after buying an additional 69 shares during the last quarter. Dohj LLC increased its holdings in shares of UnitedHealth Group by 5.6% in the 4th quarter. Dohj LLC now owns 5,749 shares of the healthcare conglomerate’s stock valued at $3,027,000 after purchasing an additional 306 shares in the last quarter. Finally, Valmark Advisers Inc. increased its holdings in UnitedHealth Group by 5.6% during the 4th quarter. Valmark Advisers Inc. now owns 6,178 shares of the healthcare conglomerate’s stock valued at $3,252,000 after acquiring an additional 326 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on UNH. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Stephens reaffirmed an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Finally, Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

NYSE UNH traded up $1.49 during mid-day trading on Friday, hitting $495.35. The company’s stock had a trading volume of 2,727,016 shares, compared to its average volume of 5,623,667. The firm has a market capitalization of $455.76 billion, a P/E ratio of 30.28, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54. The stock’s fifty day simple moving average is $485.84 and its two-hundred day simple moving average is $514.21. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.26 earnings per share. Research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.